The value of community can help psychedelics move into mainstream culture | Robert Jesse
Interview with Robert Jesse, Co-investigator, Psychiatry, & Behavioral Sciences Dept., Johns Hopkins University, USA Filmed at the Interdisciplinary Conference on Psychedelic Research (ICPR) 2024 in Haarlem, The Netherlands. Questions: 00:00 Intro 00:05 What was your first encounter with psychedelics? 02:55 What do we call a mystical type of experience? 04:38 Does mystical experience relate to the person's religious beliefs, or is it completely unrelated? 05:45 Can an atheist person have a mystical experience? 06:20 There is a kind of uncertainty with the terminology. Some people speak about hallucinogens or psychedelics or enteogens. How could you define what psychedelics are? 07:24 Aldous Huxley was one of the key persons who introduced psychedelics to the Western culture. How do you see his legacy today? 08:52 How do you define the religious use of psychedelics? 10:26 You made a significant contribution to the Johns Hopkins study on mystical types of experiences on psilocybin. Can you describe your contribution and also, can you talk about the study? 12:39 In the 60s, for many people, psychedelics served as a gateway to eastern spirituality. But as far as I know, for Roland Griffis, it was the other way. So he started to do meditation, and he was very skeptical about psychedelics first. 14:28 Can you shortly explain us the findings of the Johns Hopkins study? 15:41 Some people say Professor Griffiths imposed his religious beliefs on the research participants. Would you comment on that? 17:22 We talk a lot about how to make psychedelics part of the mainstream medical care, but how should we regulate the religious and spiritual use of psychedelics? 19:11 Do you see any signs in America, that psychedelics are abused for profit in the name of spirituality? 20:09 What can we do to mitigate those risks? 20:39 As far as I know, you have initiated a public statement in which you call for open science in the psychedelic research fields. Why do you think that is important? https://www.icpr-conference.com/ https://open-foundation.org/ / open.fndn / icpr_conference / open-foundation / @openfoundationicpr / open_fndn https://www.drugreporter.net / drugreporter Reporter: Péter Sárosi | Rights Reporter Foundation - Drugreporter Camera and editing: István Gábor Takács | Rights Reporter Foundation - Drugreporter

Michael Pollan - Psychedelics and How to Change Your Mind | Bioneers

Psychedelics as Medicine 2025 - Inside the Mind of the LSD King: Conversation with Leonard Pickard

Psychedelia - Die Erforschung der mystischen Erfahrung | Doku HD | ARTE

DMT Always Shows Shane Mauss the Same Purple Woman on His Trips - Tales From the Trip

Psychedelics help us realise the constructed nature of self | THOMAS METZINGER

Inside My Grueling 72-Hour Psychedelic Iboga Therapy

The “heroic dose” of psychedelics, according to Johns Hopkins | Dr. Matthew Johnson

Michael Pollan on Feelings, Psychedelics, and AI

Führen Drogen auf den Weg zur Erkenntnis? | Offene Ideen | ARTE

Why Gen Z Filipinos Are Giving Up on Dating and Marriage | AB Explained

The Neuroplasticity Secret: Paul Stamets on How Mushrooms Rewire the Brain

Famous Neuroscientist on 5-MeO-DMT and Integrated Information Theory | Christof Koch

The Science of Psychedelics - with Michael Pollan

Psychedelics Don't Distort Reality — They Reveal How Your Brain Constructs It

The progress on psychedelics creates momentum for broader drug policy reform | ETHAN NADELMANN

"Psilocybin Makes Nicer, Smarter and More Intelligent People" | Interview with PAUL STAMETS

Personal Experience, Benefits & Risks of Psychedelics | Tim Ferriss & Dr. Andrew Huberman

Psychedelic Assisted Therapy: Last Week Tonight with John Oliver (HBO)

The More You Study Consciousness, the Weirder It Gets | The Ezra Klein Show

